Fig. 2From: Drug interaction between methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritisChanges of participants’ disease activity scores. The figure showed the scores of SDAI and DAS28-CRP at the conclusion of SASP/MTX combination therapy (baseline, 0 weeks), and at 4, 8, 12 and 24 weeks after withdrawal of SASP. The squares indicated SDAI (■). The triangles indicated DAS28-CRP (▲). Data are mean ± SD (bars) for all assigned participants (n = 10). Comparisons were made by one-way repeated measures ANOVA with post hoc Tukey’s testBack to article page